Diazepam Market Share, Demand & SWOT Analysis by 2027, Growing at a CAGR of 3.4% - Pfizer, Mylan, Roche, Merck, Etc.
Diazepam belongs to a class of central nervous system (CNS) depressant medications used for the purpose of slowing down the nervous system.
View full press release